ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

BACKGROUND: The role and clinical value of ERβ1 expression is controversial and recent data demonstrates that many ERβ antibodies are insensitive and/or non-specific. Therefore, we sought to comprehensively characterize ERβ1 expression across all sub-types of breast cancer using a validated antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Reese, Jordan M, Suman, Vera J, Subramaniam, Malayannan, Wu, Xianglin, Negron, Vivian, Gingery, Anne, Pitel, Kevin S, Shah, Sejal S, Cunliffe, Heather E, McCullough, Ann E, Pockaj, Barbara A, Couch, Fergus J, Olson, Janet E, Reynolds, Carol, Lingle, Wilma L, Spelsberg, Thomas C, Goetz, Matthew P, Ingle, James N, Hawse, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196114/
https://www.ncbi.nlm.nih.gov/pubmed/25288324
http://dx.doi.org/10.1186/1471-2407-14-749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196114/
https://www.ncbi.nlm.nih.gov/pubmed/25288324
http://dx.doi.org/10.1186/1471-2407-14-749

Ejemplares similares